Vivanza Biosciences Q3 Results
- BSE: 530057
- NSE: -
- ISIN: INE984E01035
- Sector: Biotechnology & Drugs
BSE
1.83
-0.11 (-5.67%)
-0.11 (-5.67%)Volume25.16 K
Updated: Mon 18 May, 2026 | 15:15:00
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹45.25 Cr.(2915.71%)
- Operating Profit₹0.21 Cr.(72.24%)
- Profit After Tax₹0.20 Cr.(350.23%)
- Operating Margin0.46%(-94.29%)
Note: Comparison is on YoY basis
Quarterly - Vivanza Biosciences Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 45.04 | 2.90 | -17.74% | 6.27 | 3163.55% |
| Depreciation/ Amortization | 0.00 | 0.00 | 0.00% | 0.00 | -14.63% |
| Operating Income | 0.21 | 0.11 | -65.60% | 0.29 | 72.24% |
| Net Income | 0.20 | 0.02 | -65.29% | 0.21 | 350.23% |
| Other Operating Expenses Total | 0.09 | 0.04 | 32.23% | 0.12 | -34.91% |
| Net Income Before Taxes | 0.20 | 0.02 | -65.29% | 0.21 | 350.23% |
| Total Revenue | 45.25 | 3.00 | -18.26% | 6.56 | 2915.71% |
| Selling/ General/ Admin Expenses Total | 0.04 | 0.14 | -83.72% | 0.11 | -69.60% |
| Diluted Normalized EPS | 0.05 | 0.00 | -64.29% | 0.05 | 360.83% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.